Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites
NCT ID: NCT06375837
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
33 participants
INTERVENTIONAL
2024-04-15
2026-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Novel Alkasite Restorative Material "Cention Forte" in Class II Restorations
NCT06833528
Clinical Evaluation of Bulk-fill Restorative Materials
NCT06109987
Clinical Evaluation of a Restorative Glass Ionomer and a Composite Resin for the Restoration
NCT04266210
Clinical Comparison of Resin-hybrid Ceramic Restorations Produced Using a Computer-aided Design/Computer-aided Manufacturing (CAD/CAM) System With Fiber-reinforced Composite Restorations
NCT06496126
Restoration of Non-carious Cervical Lesions With Different Resin Composites and Universal Adhesive
NCT06393699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hybrid resin composite
Gradia Direct Anterior, GC, Tokyo, Japan (GR) After applying 37% orthophosphoric acid to the enamel of the lesions for 30 seconds and to the dentin for 15 seconds, the acid will be washed with water and then dried with light air. A universal adhesive (G-Premio Bond, GC, Tokyo, Japan) and then the composite will be applied according to the manufacturer's instructions.
hybrid resin composite
Gradia Direct Anterior
a highly filled flowable resin composite
G-aenial Universal Flo, GC, Tokyo, Japan (GF) After applying 37% orthophosphoric acid to the enamel of the lesions for 30 seconds and to the dentin for 15 seconds, the acid will be washed with water and then dried with light air. A universal adhesive (G-Premio Bond, GC, Tokyo, Japan) and then the composite will be applied according to the manufacturer's instructions.
a highly filled flowable resin composite
G-aenial Universal Flo
an alkasite-based restorative material
Cention N, Ivoclar Vivadent, Schaan, Liechtenstein (CN) The liquid and powder will be mixed and then applied according to manufacturer's instructions.
an alkasite-based restorative material
Cention N
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
an alkasite-based restorative material
Cention N
hybrid resin composite
Gradia Direct Anterior
a highly filled flowable resin composite
G-aenial Universal Flo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They will be required to have at least three NCCLs needed restoration in different teeth.
* All the NCCLs selected will be in similar sizes.
Exclusion Criteria
* Patients with rampant, uncontrolled caries
* Patients with xerostomia
* Patients with serious medical problems preventing them from attending review visits
* Patients with poor gingival health
* Patients with heavy bruxism
* Patients with removable partial dentures
* Patients undergoing bleaching treatment or orthodontic treatment
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Fatma Dilşad Öz
Assoc. Prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
bioactive-NCCLs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.